查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946426

环己胺市场 - 全球产业规模、份额、趋势、机会及预测（按类型、最终用户产业、地区和竞争格局划分，2021-2031年）

Cyclamate Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User Industry, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球环Cyclamate市场预计将从 2025 年的 20.8 亿美元成长到 2031 年的 25.8 亿美元，复合年增长率为 3.66%。

这种高强度人工甜味剂，化学名称为环己基氨基磺酸的钙盐或钠盐，其甜度约为蔗糖的30至50倍。其市场扩张主要得益于其在高温加工过程中优异的稳定性，使其成为烘焙点心的必备原料，并且与其他合成甜味剂相比具有显着的成本效益。此外，它还能协同掩盖糖精等物质的苦涩后味，因此被广泛应用于各种医药和饮料配方中。中国食品添加剂及配料协会指出，其贸易平台在2024年吸引了超过1,500家参展，显示中国拥有强大的生产能力，能够满足日益增长的全球需求。

市场概览
预测期 2027-2031
市场规模：2025年 20.8亿美元
市场规模：2031年 25.8亿美元
复合年增长率：2026-2031年 3.66%
成长最快的细分市场 饮食
最大的市场 北美洲

儘管经济指标向好，但由于世界各地监管法规的差异，市场仍面临许多障碍。美国食品药物管理局(FDA) 持续禁用Cyclamate，不仅使北美庞大的消费群体无法接触到该产品，也加剧了人们对该产品安全性的担忧。这些监管障碍有效地阻碍了该产品的国际市场拓展和普及，导致生产商和经销商面临市场分散的困境。

市场驱动因素

全球糖尿病和肥胖症发生率的不断上升，正成为Cyclamate市场的主要驱动力，促使製造商重新设计产品，推出零卡路里替代品。随着公共卫生机构将减少糖分摄取列为优先事项，食品饮料产业正迅速采用高甜度甜味剂，以在不牺牲风味的前提下降低卡路里含量。根据国际糖尿病联盟 (IDF) 预测，到 2024 年，全球 20 至 79 岁的成年人中将有约 5.89 亿人患有糖尿病，这使得低升糖指数食品的选择需求迫切。这种健康意识的转变也体现在消费者的行为中：英联食品配料公司 (Ingredion) 发布的 2024 年报告显示，标有「减血糖值」字样的包装食品销量较 2020 年增长超过 30%，凸显了商业性对使用Cyclamate甜味剂产品的强劲需求。

同时，与糖和天然甜味剂相比，Cyclamate的价格优势和成本效益仍然是其在工业应用中持续普及的关键因素。在价格敏感型市场和糖果甜点、碳酸饮料等大众消费品领域，这种甜味剂能够以远低于甜菊糖或蔗糖的成本提供浓郁的甜味，使製造商能够抵御原材料成本波动的影响，从而保障利润率。强大的供应链基础进一步巩固了这一市场地位，并透过规模经济维持了其经济优势。例如，领先的生产商金时化工（江苏）有限公司表示，其环己Cyclamate磺酸钠的年产能将在2024年保持在4万吨，从而确保为全球买家提供可靠且价格合理的供应。

市场挑战

由于区域监管差异，特别是美国食品药物管理局(FDA) 持续实施的禁令，全球环己Cyclamate市场面临严峻挑战。这种市场分散化迫使製造商为核准的市场（亚洲和欧洲）以及北美市场维护双线产品，从而阻碍了市场扩张。这些要求抵消了通常透过标准化全球配方实现的规模经济效益，增加了跨国食品饮料公司的生产成本和物流复​​杂性。

此外，美国市场对该成分安全性的排斥加剧了人们对其安全性的历史偏见，即使在允许使用该成分的地区，这种偏见也会影响消费者的看法。这种声誉障碍对消费模式产生了负面影响，阻碍了潜在的推广应用。根据国际食品资讯理事会（IFIC）2024年的数据，31%的美国消费者因安全顾虑而减少或停止摄取低热量和无热量甜味剂。这凸显了主要经济体监管部门的拒绝如何加剧负面情绪，并最终限制此类成分的销售成长和国际普及。

市场趋势

协同增效的多醣体混合物正在改变市场格局。製造商通常将Cyclamate与其他高甜度甜味剂混合使用，以获得最佳的感官特性。Cyclamate磺酸钠因其稳定性而备受推崇，但目前的市场动态主要集中在将其与糖精进行战略性组合，以抵消单一甜味剂使用时常见的金属后味。由于关键混合伙伴的监管政策更新，这种混合策略在近期获得了显着的商业性支持。 2024年，国际甜味剂协会报告称，欧洲食品安全局重申了糖精的安全性，并将可接受摄取量从每公斤体重5毫克提高到9毫克。这项措施扩大了环己基氨基磺酸钠-糖精混合物在欧洲食品和饮料行业的应用范围和允许使用量。

同时，Cyclamate作为苦味掩蔽剂在药物中的应用日益广泛，催生了对Cyclamate磺酸钠的特殊需求，尤其是在老年和儿童口服製剂领域，因为口感直接影响患者的治疗依从性。药物研发人员正积极将环己基氨基磺酸钠基辅料应用于复杂的现代活性药物成分（API）中，以抵消其令人不悦的口感，其作用也从简单的甜味剂发展到功能性味觉修饰。药物研发中普遍存在的偏好问题凸显了此应用的重要性。欧洲医学协会于2024年10月在《医学研究檔案》上发表的一项回顾性分析发现，在65%的受调查活性药物成分中，苦味是主要的掩味障碍，这凸显了新型药物对Cyclamate受体阻断特性的需求日益增长。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球环胺市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依类型（环己基氨基磺酸、环己基氨基磺酸钠、环己基氨基磺酸钙、其他）
    • 依最终使用者产业（食品饮料、医疗、化妆品等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美环胺市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲环胺市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区环胺市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲环胺市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

10. 南美洲环胺市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球环胺市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • PT. Batang Alum Industrie
  • Food Chem International Corporation
  • Productos Aditivos
  • Rasna Private Limited
  • Hangzhou Garden Corporation
  • Shanghai Rich Chemicals
  • Jinan Haohua Industry Co. Ltd.
  • Hangzhou Union Biotechnology
  • Xuchang Ruida Biology Technology
  • Rainbow Rich Industrial Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 15202

The Global Cyclamate Market is projected to expand from a valuation of USD 2.08 Billion in 2025 to USD 2.58 Billion by 2031, reflecting a CAGR of 3.66%. Chemically identified as the calcium or sodium salt of cyclamic acid, this high-intensity artificial sweetener delivers a sweetness potency approximately 30 to 50 times that of sucrose. Market expansion is primarily driven by its exceptional stability during high-temperature processing, rendering it indispensable for baked goods, alongside its substantial cost efficiency compared to other synthetic options. Additionally, its ability to synergistically mask the bitter aftertaste of substances like saccharin fuels its widespread adoption in various pharmaceutical and beverage formulations. Highlighting the industry's scale, the China Food Additives and Ingredients Association noted that in 2024, their trade platform hosted over 1,500 exhibitors, demonstrating the strong manufacturing capacity available to satisfy growing global requirements.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.08 Billion
Market Size 2031USD 2.58 Billion
CAGR 2026-20313.66%
Fastest Growing SegmentFood and Beverage
Largest MarketNorth America

Despite these positive economic indicators, the market encounters significant obstacles due to regulatory discrepancies across global jurisdictions. The enduring prohibition of cyclamate by the United States Food and Drug Administration not only blocks access to the substantial North American consumer base but also reinforces historical safety apprehensions. These regulatory barriers effectively hinder wider international acceptance and adoption of the product, creating a divided global landscape for manufacturers and distributors.

Market Driver

The rising global incidence of diabetes and obesity acts as a major catalyst for the cyclamate market, pushing manufacturers to reformulate their offerings with zero-calorie substitutes. With public health entities prioritizing sugar reduction, the food and beverage sector is rapidly integrating high-intensity sweeteners to lower caloric content without sacrificing flavor. According to the International Diabetes Federation, roughly 589 million adults aged 20-79 were living with diabetes globally in 2024, creating an urgent demographic need for low-glycemic dietary choices. This health-conscious transition is evident in consumer behavior; Ingredion reported in 2024 that sales of packaged goods with reduced-sugar claims had increased by over 30% since 2020, highlighting the commercial demand for cyclamate-sweetened products.

Concurrently, the price advantage and cost-effectiveness of cyclamate compared to sugar and natural sweeteners remain vital for its continued industrial application. In markets sensitive to price and high-volume sectors like confectionery and carbonated soft drinks, the sweetener's capacity to provide intense sweetness at a fraction of the cost of stevia or sucrose enables manufacturers to safeguard margins against volatile raw material costs. This market position is bolstered by strong supply chain infrastructures that preserve this economic benefit through economies of scale. For example, Golden Time Chemical (Jiangsu) Co., Ltd., a leading producer, reported maintaining an annual production capacity of 40,000 tons of sodium cyclamate in 2024, guaranteeing a reliable and affordable supply for global buyers.

Market Challenge

The Global Cyclamate Market contends with significant difficulties arising from regulatory disparities across different regions, particularly the persistent ban enforced by the United States Food and Drug Administration. This fragmentation impedes market expansion by compelling manufacturers to maintain dual product lines-one for approved markets like Asia and Europe, and another for the substantial North American sector. Such requirements negate the economies of scale usually gained through standardized global formulations, resulting in escalated production costs and increased logistical complexity for multinational food and beverage companies.

Moreover, exclusion from the U.S. market reinforces historical stigma regarding the ingredient's safety, impacting consumer views even in jurisdictions where it is permitted. This reputational hurdle negatively influences consumption patterns and discourages potential uptake. Data from the International Food Information Council in 2024 indicated that 31% of U.S. consumers reduced or ceased consumption of low- and no-calorie sweeteners specifically due to safety concerns. This highlights how regulatory rejection in a major economy perpetuates negative sentiment, ultimately constraining the ingredient's volume growth and broader international adoption.

Market Trends

The trend of adopting synergistic multi-sweetener blending formulations is transforming the market, as manufacturers frequently combine cyclamate with other high-intensity sweeteners to achieve optimized sensory profiles. Although cyclamate is prized for its stability, current market dynamics focus on its strategic pairing with saccharin to neutralize the metallic aftertaste often found in single-sweetener applications. This formulation strategy recently gained significant commercial support due to regulatory updates concerning its main blending partner. In 2024, the International Sweeteners Association noted that the European Food Safety Authority reaffirmed saccharin's safety and raised its Acceptable Daily Intake from 5 to 9 mg/kg body weight per day, a move that expands the application scope and permissible volume for these cyclamate-saccharin blends within the European food and beverage industry.

At the same time, the increasing use of cyclamate as a bitterness masking agent in pharmaceuticals is generating specialized demand, especially for geriatric and pediatric oral formulations where taste directly impacts therapeutic compliance. Drug developers are actively incorporating cyclamate-based excipients to counteract the unpleasant taste profiles of complex modern active pharmaceutical ingredients (APIs), advancing from simple sweetening to functional taste modification. The critical nature of this application is highlighted by prevalent palatability issues in drug creation. A retrospective analysis published in the 'Medical Research Archives' by the European Society of Medicine in October 2024 found that bitterness was the primary taste-masking obstacle for 65% of the drug actives reviewed, emphasizing the growing need for cyclamate's receptor-blocking properties in new medicinal products.

Key Market Players

  • PT. Batang Alum Industrie
  • Food Chem International Corporation
  • Productos Aditivos
  • Rasna Private Limited
  • Hangzhou Garden Corporation
  • Shanghai Rich Chemicals
  • Jinan Haohua Industry Co. Ltd.
  • Hangzhou Union Biotechnology
  • Xuchang Ruida Biology Technology
  • Rainbow Rich Industrial Ltd

Report Scope

In this report, the Global Cyclamate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cyclamate Market, By Type

  • Cyclamic Acid
  • Sodium Cyclamate
  • Calcium Cyclamate
  • Others

Cyclamate Market, By End User Industry

  • Food and Beverage
  • Healthcare
  • Cosmetics
  • Others

Cyclamate Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cyclamate Market.

Available Customizations:

Global Cyclamate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cyclamate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Cyclamic Acid, Sodium Cyclamate, Calcium Cyclamate, Others)
    • 5.2.2. By End User Industry (Food and Beverage, Healthcare, Cosmetics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cyclamate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User Industry
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cyclamate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User Industry
    • 6.3.2. Canada Cyclamate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User Industry
    • 6.3.3. Mexico Cyclamate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User Industry

7. Europe Cyclamate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User Industry
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cyclamate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User Industry
    • 7.3.2. France Cyclamate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User Industry
    • 7.3.3. United Kingdom Cyclamate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User Industry
    • 7.3.4. Italy Cyclamate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User Industry
    • 7.3.5. Spain Cyclamate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User Industry

8. Asia Pacific Cyclamate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User Industry
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cyclamate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User Industry
    • 8.3.2. India Cyclamate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User Industry
    • 8.3.3. Japan Cyclamate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User Industry
    • 8.3.4. South Korea Cyclamate Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User Industry
    • 8.3.5. Australia Cyclamate Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User Industry

9. Middle East & Africa Cyclamate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User Industry
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cyclamate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User Industry
    • 9.3.2. UAE Cyclamate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User Industry
    • 9.3.3. South Africa Cyclamate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User Industry

10. South America Cyclamate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User Industry
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cyclamate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User Industry
    • 10.3.2. Colombia Cyclamate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User Industry
    • 10.3.3. Argentina Cyclamate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User Industry

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cyclamate Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. PT. Batang Alum Industrie
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Food Chem International Corporation
  • 15.3. Productos Aditivos
  • 15.4. Rasna Private Limited
  • 15.5. Hangzhou Garden Corporation
  • 15.6. Shanghai Rich Chemicals
  • 15.7. Jinan Haohua Industry Co. Ltd.
  • 15.8. Hangzhou Union Biotechnology
  • 15.9. Xuchang Ruida Biology Technology
  • 15.10. Rainbow Rich Industrial Ltd

16. Strategic Recommendations

17. About Us & Disclaimer